Process for the preparation of epoprostenol sodium of enhanced stability

The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it con...

Full description

Saved in:
Bibliographic Details
Main Authors TORMASI, ROBERTNE, KARDOS, ZSUZSANNA, MOLNAR, JOZSEF, HORTOBAGYI, IREN, TAKACS, LASZLO, LASZLOFI, ISTVAN
Format Patent
LanguageChinese
English
Published 16.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it contains in 3-7.5 mass% inorganic base or basic-hydrolyzing inorganic salt.
Bibliography:Application Number: TW20176109275